Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.8.0.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2018
Jun. 30, 2017
Current assets :    
Cash $ 8,298 $ 14,326
Accounts receivable (net of allowance of $0 and $0, respectively) 382
Inventory 125,851 95,865
Other current assets 2,322 3,491
Total current assets 136,471 114,064
Total assets 136,471 114,064
Current liabilities:    
Accounts payable 184,535 205,961
Accrued expense-related party 198,000 180,000
Convertible notes payable - net of discount 534,540 151,020
Fair value of derivative liabilities 1,392,413 44,022
Short-term borrowings 1,600 3,096
Advance from shareholders 995
Total current liabilities 2,311,088 585,094
Commitments and contingencies
Stockholders' deficit:    
Common stock, ($0.001 par value, 200,000,000 shares authorized, and 39,548,798 issued and outstanding as of March 31, 2018 and 29,724,432 outstanding as of June 30, 2017, respectively) 39,549 29,724
Additional paid in capital 4,745,370 2,880,467
Accumulated deficit (6,959,536) (3,381,221)
Total stockholders' deficit (2,174,617) (471,030)
Total Liabilities and Stockholders' Deficit $ 136,471 $ 114,064